Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
Masashi Miyamoto to be named Chairman and CEOAbdul Mullick to be named President and COOChanges designed to further deliver on company's 2030 Vision and commitment to advancing novel treatments for